Saad J Taj-Aldeen1, Anand Deshmukh1, Sanjay Doiphode1, Atqah Abdul Wahab2, Mona Allangawi3, Ahmed Almuzrkchi4, Corné H Klaassen5, Jacques F Meis5. 1. Microbiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar; 2. Department of Pediatric, Hamad Medical Corporation, Doha, Qatar; 3. Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar; 4. Department of Radiology, Hamad Medical Corporation, Doha, Qatar; 5. Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Abstract
BACKGROUND: Nocardia species are rare, opportunistic organisms that cause disease in both immunocompetent and immunocompromised individuals. OBJECTIVE: To investigate the clinical presentations of various Nocardia infections based on the 16S ribosomal RNA gene of the isolate, as well as related risk factors and susceptibility patterns to antimicrobial agents. METHODS: Thirteen patients with a diagnosis of nocardiosis were included in the present study. Seven Nocardia species were identified by 16S ribosomal RNA. Susceptibility testing was performed using six antimicrobial agents. RESULTS: Five patients were immunocompromised, and eight were immunocompetent with predisposing factors including cystic fibrosis, tuberculosis and ophthalmic infections. Nocardia caused pulmonary infections in eight patients (61.5%), invasive systemic infections in three patients (23%) and local (ophthalmic) infections in two patients (15.4%). In the patients with pulmonary disease, nocardiosis was caused by six species (Nocardia cyriacigeorgica, Nocardia otitidiscaviarum, Nocardia farcinica, Nocardia carnea, Nocardia testacea and Nocardia asiatica). The seventh species identified in the present study was Nocardia crassostreae. DISCUSSION: N crassostreae is a multidrug-resistant organism that was reported to be an emerging human pathogen causing invasive nocardiosis in a patient with non-Hodgkin's lymphoma. N farcinica was isolated from blood in a patient with breast cancer. None of the Nocardia isolates were resistant to linezolid. One N otitidiscaviarum isolate was a multidrug-resistant organism. All patients in the present study were treated with the appropriate antibiotics and their condition resolved without further sequelae. CONCLUSIONS: The present study is the first report on N crassostreae as a human pathogen. The detection of multidrug-resistant species necessitate molecular identification and susceptibility testing, and should be performed for all Nocardia infections. Nocardiosis manifests various clinical features depending on the Nocardia species and underlying conditions.
BACKGROUND:Nocardia species are rare, opportunistic organisms that cause disease in both immunocompetent and immunocompromised individuals. OBJECTIVE: To investigate the clinical presentations of various Nocardia infections based on the 16S ribosomal RNA gene of the isolate, as well as related risk factors and susceptibility patterns to antimicrobial agents. METHODS: Thirteen patients with a diagnosis of nocardiosis were included in the present study. Seven Nocardia species were identified by 16S ribosomal RNA. Susceptibility testing was performed using six antimicrobial agents. RESULTS: Five patients were immunocompromised, and eight were immunocompetent with predisposing factors including cystic fibrosis, tuberculosis and ophthalmic infections. Nocardia caused pulmonary infections in eight patients (61.5%), invasive systemic infections in three patients (23%) and local (ophthalmic) infections in two patients (15.4%). In the patients with pulmonary disease, nocardiosis was caused by six species (Nocardia cyriacigeorgica, Nocardia otitidiscaviarum, Nocardia farcinica, Nocardia carnea, Nocardia testacea and Nocardia asiatica). The seventh species identified in the present study was Nocardia crassostreae. DISCUSSION: N crassostreae is a multidrug-resistant organism that was reported to be an emerging human pathogen causing invasive nocardiosis in a patient with non-Hodgkin's lymphoma. N farcinica was isolated from blood in a patient with breast cancer. None of the Nocardia isolates were resistant to linezolid. One N otitidiscaviarum isolate was a multidrug-resistant organism. All patients in the present study were treated with the appropriate antibiotics and their condition resolved without further sequelae. CONCLUSIONS: The present study is the first report on N crassostreae as a human pathogen. The detection of multidrug-resistant species necessitate molecular identification and susceptibility testing, and should be performed for all Nocardia infections. Nocardiosis manifests various clinical features depending on the Nocardia species and underlying conditions.
Authors: M V Parande; R S Shinde; B G Mantur; A M Parande; M R Chandrashekhar; P S Aralikatti; E Palled Journal: Indian J Med Microbiol Date: 2010 Oct-Dec Impact factor: 0.985
Authors: S Jimenez-Galanes Marchan; J C Meneu Díaz; O Caso Maestro; B Perez Saborido; A Moreno Elola-Olaso; M Abradelo Usera; Y Fundora Suarez; A Gimeno Calvo; V Moreno Molinero; A Garcia Reyne; V Barra Valencia; R San Juan Garrido; E Moreno Gonzalez Journal: Transplant Proc Date: 2009 Jul-Aug Impact factor: 1.066
Authors: M J Agterof; T van der Bruggen; M Tersmette; E J ter Borg; J M M van den Bosch; D H Biesma Journal: Neth J Med Date: 2007-06 Impact factor: 1.422
Authors: Francesca Carella; Serena Aceto; Olga Mangoni; Maria Pina Mollica; Gina Cavaliere; Giovanna Trinchese; Francesco Aniello; Gionata De Vico Journal: Front Physiol Date: 2018-06-12 Impact factor: 4.566
Authors: J Francis Borgio; Alia Saeed Rasdan; Bayan Sonbol; Galyah Alhamid; Noor B Almandil; Sayed AbdulAzeez Journal: Biology (Basel) Date: 2021-11-06